Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cirstea

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Leukemia|August 6, 2013
Histone deacetylase 3 as a novel therapeutic target in multiple myelomaJ Minami, R Suzuki, R Mazitschek, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
British Journal of Haematology|April 26, 2014
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomideAndrew J Yee, Parameswaran Hari, Raffaella Marcheselli, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Cell Reports|February 10, 2015
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic ProgenitorsShrikanta Chattopadhyay, Alison L Stewart, Siddhartha Mukherjee, et al.
Blood|January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory DiarrheaViktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Leukemia|August 6, 2013
Histone deacetylase 3 as a novel therapeutic target in multiple myelomaJ Minami, R Suzuki, R Mazitschek, et al.
Oncogene|January 27, 2010
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibitionL Santo, S Vallet, T Hideshima, et al.
British Journal of Haematology|April 26, 2014
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomideAndrew J Yee, Parameswaran Hari, Raffaella Marcheselli, et al.
Leukemia|January 20, 2009
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaN Raje, T Hideshima, S Mukherjee, et al.
Cell Reports|February 10, 2015
Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic ProgenitorsShrikanta Chattopadhyay, Alison L Stewart, Siddhartha Mukherjee, et al.
Blood|January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory DiarrheaViktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
Pageof 2